Representative Faculty Publications as of May, 2008:

(for more current publications, please select the specific faculty member for their link to PubMed)


ORIGINAL REPORTS

Shelly F. Greenfield, MD, MPH

Truco  EM, Connery HS, Griffin ML, Greenfield SF. The relationship of self esteem and self-efficacy to treatment outcomes of alcohol dependent men and women. Am J Addict. 2007;16(2):85-92.

Greenfield SF, Trucco EM, McHugh RK, Lincoln M, Gallop RJ: The Women’s Recovery Group Study: A Stage I Trial of Women-Focused Group Therapy for Substance Use Disorders versus Mixed-Gender Group Drug Counseling. Drug Alcohol Depend. 2007;90:39-47.

Donovan DM, Kivlahan DR, Doyle SR, Longabaugh R, Greenfield SF: Concurrent validity of the AUDIT and AUDIT zones in defining levels of severity among outpatients with alcohol dependence in the Combine Study. Addiction 2006; 101(12): 1696-704.

Greenfield SF, Brooks AJ, Gordon SM, Green CA, Kropp F, McHugh RK,  Lincoln M, Hien D Miele G: Substance abuse treatment entry, retention, and  outcome in women: A review of the literature. Drug Alcohol Depend 2007; 86: 1-21.

Wasan A, Michna E, Janfaza D, Greenfield SF, Teter C, Jamison R: Interpreting Urine Drug Tests:  Prevalence of Morphine Metabolism to Hydromorphone in Chronic Pain Patients Treated with Morphine. Pain Medicine (in press).

Iannucci R, Sanders K, Greenfield SF: A four-year longitudinal curriculum for adult psychiatry residents in the treatment of substance use disorders. Academic Psychiatry, in press.

Gordon S, Johnson A, Greenfield SF, Cohen L, Killeen T, Roman P. Assessment and Treatment of Co-occurring Eating Disorders in Publicly Funded Addiction Treatment Programs. Psychiatric Services. In press.

Greenfield SF, Sugarman DE, Nargiso J, Weiss RD: Readability of patient handout materials in a nationwide sample of alcohol and drug abuse treatment programs. Amer J Addict 2005; 14: 339-345.

Greenfield SF: Is parity for the treatment of substance related disorders really sensible? Psychiatric Services2005; 56: 153-155.

Greenfield, SF, Gordon S, Cohen, L, Trucco, E: Treatment of co-occurring substance use and eating disorders. In: Nuñes EV, Hennessy G, and Selzer J, eds., Substance Dependence and Co-Occurring Psychiatric Disorders: Best Practices for Diagnosis and Treatment. In press. 

Greenfield SF, Hennessy G: Assessment of the Patient. In: Galanter, M and Kleber HD, eds., Textbook of Substance Abuse Treatment, 4th Edition, Washington D.C., American Psychiatric Journal, (in press).

Olivera Bogunovic, MD

Madhusoodanan S, Bogunovic OJ. Safety of Benzodiazepines in the Geriatric Population. Expert Opin Drug Saf. 2004 Sep;3(5):485-93.

Bogunovic OJ, Greenfield SF. Practical geriatrics: Use of Benzodiazepines among elderly patients. Psychiatr Serv. 2004 Mar;55(3):233-5.

Alisa Busch, MD, MS

Busch A, Frank RG, Lehman A, Greenfield SF: Schizophrenia, co-occurring substance use disorders and quality of care: The differential effect of a managed behavioral   health care carve-out.  Administration and Policy in Mental Health and Mental Health Services Research.  Psychiatric Services 2006; 33(3): 388-397.

Busch A, Ling D, Frank RG, Greenfield SF: Changes in bipolar-I disorder quality    of care during the 1990’s. Psychiatric Services 2007; 58: 27-33.

Hilary Connery, MD, PhD

Connery, HS, McHugh K, Greenfield, SF: How well does AA work? That’s (partly) up to you. Current Psychiatry 2005; May 4(5): 1-6.

Truco  EM, Connery HS, Griffin ML, Greenfield SF. The relationship of self esteem and self-efficacy to treatment outcomes of alcohol dependent men and women. Am J Addict. 2007;16(2):85-92.

Eden Evins, MD

Barr RS, Pizzagalli, DA, Culhane MA, Goff DC, Evins AE. A Single Dose of Nicotine Enhances Reward Responsiveness in Nonsmokers: Implications for Development of Dependence. Biol Psych. (In press).

Barr RS, Culhane MA, Jubelt LE, Mufti RS, Dyer MA, Weiss AP, Kelly JF, Freudenreich O, Goff DC, Evins AE. The effects of transdermal nicotine on cognition in non-smokers with and without schizophrenia: A randomized, placebo-controlled trial. Neuropsychopharmacology. 2007 April 18 Electronic publicationahead of print

Evins AE, Cather C, Freudenreich O, Birnbaum A, Culhane MA, Horowitz J, Zhang H, Hsieh E, Henderson DC, Schoenfeld DA, Rigotti NA, Goff DC. A 12-week, double-blind, placebo-controlled trial of bupropion SR added to nicotine replacement therapy for smoking cessation in schizophrenia. J Clin Psychopharmacology 2007 Aug;27(4): 380-386.

Pizzagalli DA, Evins AE, Schetter EC, Frank MJ, Patjas PE, Santesso DL, Culhane MA. Single Dose of a Dopamine Agonist Impairs Reinforcement Learning in Humans: Behavioral Evidence from a Laboratory-based Measure of Reward Responsiveness. Psychopharmacology. Oct 2, 2007 epub ahead of print (In Press).

David S, Lancaster T, Stead LF, Evins AE. Opioid antagonists for smoking cessation. Cochrane Database of Systematic Reviews. 2006 Oct 18(4):CD003086).

David SP, Strong D, Brown RA, Lloyd-Richardson EE, Evins AE, Wileyto EP, Shields PG, Lerman C, Niaura R. Bupropion efficacy for smoking cessation is influenced by the DRD2-Taq1A polymorphism. Nicotine and Tobacco Research (In Press)

Gelenberg AJ, DeLeon J, Evins AE, Park JJ, Rigotti NA. Smoking cessation in patients with psychiatric Illness. Journal of Clinical Psychiatry. (In press).

Gottlieb JD, Evins AE. Nicotine dependence treatment for smokers with schizophrenia, A practical guide for clinicians. Current Psychiatry. (In Press).

Henderson DC, Copeland PM, Borba CP, Daley TB, Nguyen DD, Cagliero E, Evins AE, Zhang H, Hayden D, Freudenreich O, Cather C, Schoenfeld D, Goff DC. Glucose metabolism in patients with schizophrenia treated with olanzapine or quetiapine: a frequently sampled intravenous glucose tolerance test and minimal model analysis. J Clin Psych 2006 May;67(5):789-97.

Henderson  DC, Fan X, Copeland PM, Borba CP, Daley TB, Nguyen  DD, Zhang H, Hayden D, Freudenreich O, Cather C, Evins AE, Goff DC. A double-blind,  placebo-controlled trial of sibutramine for clozapine-associated weight  gain.  Acta    Psychiatrica Scandinavica  2007 Feb;115(2):101-5.

Fan X, Henderson DC, Chiang E, Cather C, Freudenreich O, Evins AE, Goff DC. Sexual functioning, psychopathology and quality of life in patients with schizophrenia. Schiz Res. 2007 Aug; 94(1-3): 119-27.

Henderson DC, Borba CP, Daley TB, Boxill R, Nguyen DD, Culhane MA, Louie PM, Cather C,  Evins AE, Freudenreich O, Taber SM, Goff DC. Dietary intake profile of patients with schizophrenia. Annals of Clin Psychiatry. (In press).

Henderson DC, Copeland PM, Nguyen DD, Borba CP, Cather C, Evins AE, Freudenreich O, Baer L, Goff DC. Homocysteine levels and glucose metabolism in non-obese, non-diabetic chronic schizophrenia. Acta Psychiatr Scand. (In press).

Dyer M, Barr RS, Evins AE. Nicotinic and Glycinergic Medications for Disorders of Hedonic Regulation. Letters in Drug Design and Discovery. 2007;4 (In press).

Cather CA, Barr RS, Evins AE. Smoking and Schizophrenia:  Prevalence, Mechanisms and Implications for Treatment. Clinical Schizophrenia and Related Psychoses. (In press).

Evins AE , Nierenberg AA, Demopulos C, Eisner LR, Sachs GS. Donepezil augmentation of lithium or valproate for treatment resistant mania. Bipolar Disord. 2006:8:75-80.

Evins AE , Yovel I, Nierenberg AA, Demopulos C, Eisner LR, Ogutha J, Grandin LD, Sachs GS. Inositol augmentation of lithium or valproate for treatment resistant bipolar depression. Bipolar Disord. 2006:8:1-7.

Henderson DC, Kunkel L, Nguyen DD, Borba CP, Daley TB, Louie PM, Freudenreich O, Cather C, Evins AE, Goff DC. An exploratory open label trial of aripiprazole as an adjuvant to clozapine therapy in chronic schizophrenia. Acta Psychiatr Scand. 2006 Feb;113(2):142-7.

Roger D Weiss, MD

Weiss RD, Griffin ML. Kolodziej ME, Greenfield SF, Najavits LM, Daley DC, Doreau HR, Hennen JA. A randomized trial of integrated group therapy versus drug counseling for patients with bipolar disorder and substance dependence. Am J Psychiatry.2007; 164(1):100-107.

Meade CS, Graff FS, Griffin ML, Weiss RD. HIV risk behavior among patients with co-occurring bipolar and substance use disorders: Association with mania and drug abuse. Drug Alcohol Depend. 2007[Epub ahead of print].

Meade C, Weiss R. Substance abuse as a risk factor for HIV sexual risk behavior among persons with severe mental illness: Review of evidence and exploration of mechanisms Clinical Psychology: Science and Practice, in press.

Crits-Christoph P, Gibbons MBC, Barber JP, Gallop R, Weiss RD.  Predictor of sustained abstinence during psychosocial treatments for cocaine dependence.  J Psychother Pract Res, in press.

Kolodziej ME, Griffin ML, Bender R, Weiss RD. Assessment of depressive symptoms severity among patients with co-occurring bipolar disorder and substance dependence. J Affect Disord 2007[Epub ahead of print].

Jaffee W, Trucco E, Levy S, Weiss R. Is this Urine Really Negative? A Systematic Review of Tampering Methods in Urine Drug Screening and Testing. J Subst Abuse Treat 2007; 33(1): 33-42.

Kranzler HR, Wilcox M, Weiss RD, Brady K, Hesselbrock V, Rounsaville B, Farrer L, Gelernter J. The validity of cocaine dependence subtypes. Addict Behav. 2007;[Epub in press].

Ostacher M, Nierenberg A, Perlis R, Eidelman P, Borrelli DJ, Tran TB, Ericson GM, Weiss RD, Sachs GS. The association between smoking, suicidal behavior, comorbidity, and course of illness in bipolar disorder. J Clin Psychiatry 2006; 67(12):1907-1911.
                                               
Weiss R, Kueppenbender K. Combining Psychosocial Treatment with Pharmacotherapy for Alcohol Dependence. Journal Clin  Psychopharmacol 2006.;26 Suppl 1: :S 37-42.

Work Group on Substance Use Disorders, Kleber HD Miller WR, Baca C, Compton WM, Ernst D, Manuel JK, Pringle B, Schermer CR, Weiss RD, Willenbring ML, Zweben A. Addressing substance abuse in health care settings. Alcohol Clin Exp Res. 2006; 30(2):292-302.

Anton RF, O'Malley SS, Ciraulo DA, Cisler RA, Couper D, Donovan DM, Gastfriend DR, Hosking JD, Johnson BA, LoCastro JS, Longabaugh R, Mason BJ, Mattson ME, Miller WR, Pettinati HM, Randall CL, Swift R, Weiss RD, Williams LD, Zweben, A. Combined pharmacotherapies and behavioral interventions for alcohol dependence: The COMBINE Study: A randomized controlled trial.  JAMA 2006; 295(17):2003-2017.

Fossey MD, Otto MW, Yates WR, Wisniewski SR, Gyulai L, Allen MH, Miklowitz DJ, Coon KA, Ostacher MJ, Neel JL, Thase ME, Sachs GS, Weiss RD, Investigators FS. Validity of the Distinction Between Primary and Secondary Substance Use Disorder in Patients with Bipolar Disorder: Data from the First 1000 STEP-BD Participants. Am J Addict. 2006;15(2):138-143.

Gelernter J, Panhuysen C, Wilcox M, Hesselbrock V, Rounsaville B, Poling J, Weiss RD, Sonne S, Zhao H, Farrer L, Kranzler HR. Genomewide linkage scan for opioid dependence and related traits. Am J Hum Genet. 2006;78(5):759-769.

Yu Y, Panhuysen C, Kranzler HR, Hesselbrock V, Rounsaville B, Weiss RD, Brady K, Farrer LA, Gelernter J. Intronic variants in the dopa decarboxylase (DDC) gene are associated with smoking behavior in European-Americans and African-Americans. Hum Mol Genet. 2006;15(14):2192-2199.

Otto MW, Simon NM, Wisniewski SR, Miklowitz DJ, Kogan JN, Reilly-Harrington NA, Frank E, Nierenberg AA, Marangell LB, Sagduyu K, Weiss RD, Miyahara S, Thase ME, Sachs GS, Pollack MH. Prospective 12-month course of bipolar disorder in out-patients with and without comorbid anxiety disorders. Br J Psychiatry. 2006;189:20-25.

Najavits LM, Gallop RJ, Weiss RD. Seeking Safety Therapy for Adolescent Girls with PTSD and Substance Use Disorder: A Randomized Controlled Trial. J Behav Health Serv Res. 2006.

Kalayasiri R, Kranzler HR, Weiss RD, Brady K, Gueorguieva R, Panhuysen C, Yang B Z, Farrer L, Gelernter J, Malison RT. Risk factors for cocaine-induced paranoia in cocaine-dependent sibling pairs. Drug Alcohol Depend. 2006;84(1):77-84.

Harned MS, Najavits LM, Weiss RD. Self-Harm and Suicidal Behavior in Women with Comorbid PTSD and Substance Dependence. Am J Addict. 2006;15(5):392-395.

Barber JP, Gallop R, Crits-Christoph P, Frank A, Thase ME, Weiss RD, Connolly Gibbons MB. The role of therapist adherence, therapist competence, and the alliance in predicting outcome of individual drug counseling: Results from the NIDA Collaborative Cocaine Treatment Study.  Psychother Res, in press.

Gelernter J, Yu Y, Weiss RD, Brady K, Panhuysen C, Yang B, Kranzler H, Farrer L. Haplotype spanning TTC12 and ANKK1, flanked by the DRD2 and NCAM1 Loci, is strongly associated to nicotine dependence in two distinct American populations. Hum Mol Genet, in press.

Shields AL, Howell RT, Potter JS, Weiss RD.  The Michigan Alcoholism Screening Test and its shortened forms: A meta-analytic inquiry into score reliability.  Subst Use Misuse, in press.

Miller CS, Shields AL, Campfield D, Wallace KA, Weiss RD. Substance use scales of the Minnesota Multiphasic Personality Inventory: An exploration of score reliability via meta-analysis.  Educational and Psychological Measurement, in press.

Gelernter J, Panhuysen C, Weiss RD, Brady K, Poling J, Krauthammer M, Farrer L, Kranzler HR. Genomewide linkage scan for nicotine dependence: Identification of a novel chromosome 5 risk locus. Biol Psychiatry, in press.

Pomykacz B, Mao M, Weiss RD, Teter CJ. A review of brief medication adherence instruments in patients with schizophrenia and bipolar disorder. Harv Rev    Psychiatry. 2007;15(5):250-263.

Pomykacz B, Mao M, Weiss RD, Teter CJ. A review of brief medication adherence instruments in patients with schizophrenia and bipolar disorder. Harv Rev Psychiatry.2007;15(5):250-263.

Manwani SG, Szilagyi KA, Zablotsky B, Hennen J, Griffin ML, Weiss RD. Adherence to pharmacotherapy in bipolar patients with and without co-occurring substance use disorders. J Clin Psychiatry 2007;68(8): 1172-1176.


PRACTICE GUIDELINES AND COMMUNICATIONS

Kleber HD, Weiss RD, Anton RF Jr, George TP, Greenfield SF, Kosten TR, O’Brien CP, Rounsaville BJ, Strain EC, Ziedonis DM, Hennessy G, Connery HS, McIntyre JS, Charles SC, Anzia DJ, Cook IA, Finnerty MT, Johnson BR, Nininger JE, Summergrad P, Woods SM, Yager J, Pyles R, Cross CD, Peele R, Shemo JP, Lurie L, Walker RD, Barnowitz MA, Gray SH, Saxena S, Tonnu T, Kunkle R, Albert AB, Fochtmann LJ, Hart C, Regier D; Work group on Substance Use Disorders; American Psychiatric Association;Steering Committee on Practice Guidelines. Treatment of patients with substance use disorders, second edition. American Psychiatric Association. Am J Psychiatry.2007 Apr;164( 4 Suppl): 5-123.


BOOKS AND EDITED VOLUMES

Brady K, Back S, Greenfield SF, Eds: Women and Addiction: A Comprehensive Textbook, New York, Guilford Publications (in press).

Pettinati HM, Weiss RD, Miller WR, Donovan D, Rounsaville BJ, Ernst D, authors. Medical Management (MM) Treatment Manual: A Guide for Medically Trained Clinicians Providing Pharmacotherapy as Part of the Treatment for Alcohol Dependence. Rockville, MD: National Institute on Alcohol Abuse and Alcoholism .Monograph, in press.

Greenfield SF. The Women’s Recovery Group Treatment Manual. New York, Guilford Publications (in press, summer, 2009).